Price Chart

Headline
Wire
Time (ET)
DATE TIME TYPE PERIOD REPORTED
EPS
ESTIMATED
EPS
SURPRISE
07/29/2022* -- Results Q2 2022 -- -0.11 --
07/29/2022* 16:30 EST Earnings Call Q2 2022 -- -- --
05/05/2022 -- Results Q1 2022 -0.13 -0.03 -387.4%
05/05/2022 16:30 EST Earnings Call Q1 2022 -- -- --
02/24/2022 -- Results Q4 2021 -0.03 0.03 -192.3%
02/24/2022 16:30 EST Earnings Call Q4 2021 -- -- --
10/28/2021 -- Results Q3 2021 0.07 0.02 250.0%
10/28/2021 16:30 EST Earnings Call Q3 2021 -- -- --
*Estimated Date/Time

Earnings

Next Report Date 07/29/2022 (est.)
EPS Estimate Upgrade
Last Actual EPS Upgrade

Loading chart...
Last Report Date 05/05/2022
Beat/Miss Upgrade
Return Since -25.81%
Last FQE 03/31/2022
Next FQE 06/30/2022

Profile

Edit
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a leading provider of genomics-based information for transplant patients. Its primary operations are in Brisbane, California; Omaha, Nebraska; Fremantle, Australia and Stockholm, Sweden.
URL https://www.caredx.com
Investor Relations URL https://investors.caredxinc.com/
HQ State/Province California
Sector Healthcare
Industry Diagnostics & Research
Equity Style Small Cap/Growth
Next Earnings Release Jul. 29, 2022 (est.)
Last Earnings Release May. 05, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Dividends

Dividend Per Share (TTM) --
2017
2018
2019
2020
2021
No data available
 
6.00%
4.00%
2.00%
 
Yield to Market 0.00
Yield to Sector 0.00
Yield to Industry 0.00
Last Dividend Amt. --
Dividend Frequency --
Last Ex-Dividend Date --
Yield (TTM) 0%
Forward Yield --
Payout Ratio 0.00%
Cash Payout Ratio 0.00%
Consistent Payer (5Y) No
Consistent Growth (5Y) No

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Total Returns Comparison

Edit comparables

Annual Total Returns Versus Peers

Edit comparables
Loading chart...
Name
2015
2016
2017
2018
2019
2020
2021
YTD
-11.72%
-57.81%
171.9%
242.5%
-14.20%
235.9%
-37.23%
-48.35%
1.38%
11.96%
21.83%
-4.38%
31.49%
18.40%
28.71%
-17.56%
--
--
--
-47.66%
56.34%
101.7%
-17.43%
-94.13%
66.00%
45.78%
148.8%
-26.02%
-9.43%
116.2%
-24.31%
26.77%
8.71%
-27.18%
386.7%
-44.96%
-34.33%
-21.24%
-20.53%
-68.91%
--
--
--
--
--
-50.52%
-54.57%
-80.98%
As of June 27, 2022.

Profile

Edit
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a leading provider of genomics-based information for transplant patients. Its primary operations are in Brisbane, California; Omaha, Nebraska; Fremantle, Australia and Stockholm, Sweden.
URL https://www.caredx.com
Investor Relations URL https://investors.caredxinc.com/
HQ State/Province California
Sector Healthcare
Industry Diagnostics & Research
Equity Style Small Cap/Growth
Next Earnings Release Jul. 29, 2022 (est.)
Last Earnings Release May. 05, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Top Fund Holders

Symbol Dollars Invested % Weight
EAGB.NO 607588.0 USD 4.13%
ARKG 96.98M USD 3.70%
JFWD 110751.0 USD 3.36%
GNOM 4.987M USD 2.69%
JSCGX 270656.0 USD 2.07%
AASOX 4.343M USD 2.01%
ASIRX 4.781M USD 2.01%
ASCYX 9.704M USD 1.89%
BDFUX 27.71M USD 1.80%
RVPIX 3.773M USD 1.57%

Top Portfolio Holders

0 of 0

Other Resources

Whale Wisdom 13F Filings
Seeking Alpha Call Transcripts
Morningstar Insider Trading
Nasdaq Institutional Ownership
Nasdaq Option Chain
SEC SEC Filings
Twitter CDNA Tweets